{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T02:56:45Z","timestamp":1768273005534,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,23]]},"DOI":"10.7759\/cureus.28299","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T13:23:50Z","timestamp":1661261030000},"source":"Crossref","is-referenced-by-count":10,"title":["Fixed Drug Eruption: An Underrecognized Cutaneous Manifestation of a Drug Reaction in the Primary Care Setting"],"prefix":"10.7759","author":[{"given":"George","family":"Shaker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teja","family":"Mehendale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"De La Rosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000249368","article-title":"Fixed drug eruptions in children: a series of 23 cases with provocative tests","volume":"172","author":"Kanwar AJ","year":"1986","unstructured":"Kanwar AJ, Bharija SC, Belhaj MS. Fixed drug eruptions in children: a series of 23 cases with provocative tests. Dermatologica. 1986, 172:315-8. 10.1159\/000249368","journal-title":"Dermatologica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.14423\/SMJ.0000000000000195","article-title":"Fixed drug eruptions: presentation, diagnosis, and management","volume":"107","author":"Flowers H","year":"2014","unstructured":"Flowers H, Brodell R, Brents M, Wyatt JP. Fixed drug eruptions: presentation, diagnosis, and management. South Med J. 2014, 107:724-7. 10.14423\/SMJ.0000000000000195","journal-title":"South Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_481_17","article-title":"Fixed-drug eruptions: What can we learn from a case series?","volume":"63","author":"Jhaj R","year":"2018","unstructured":"Jhaj R, Chaudhary D, Asati D, Sadasivam B. Fixed-drug eruptions: What can we learn from a case series?. Indian J Dermatol. 2018, 63:332-7. 10.4103\/ijd.IJD_481_17","journal-title":"Indian J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2014.09.049","article-title":"Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome","volume":"48","author":"Dharamsi FM","year":"2015","unstructured":"Dharamsi FM, Michener MD, Dharamsi JW. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome. J Emerg Med. 2015, 48:551-4. 10.1016\/j.jemermed.2014.09.049","journal-title":"J Emerg Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.03.033","article-title":"Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report","volume":"10","author":"Lellig E","year":"2022","unstructured":"Lellig E, Mouton-Faivre C, Abs D, Bursztejn AC. Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report. J Allergy Clin Immunol Pract. 2022, 10:1922-3. 10.1016\/j.jaip.2022.03.033","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0091-6749(03)01624-5","article-title":"IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption","volume":"112","author":"Teraki Y","year":"2003","unstructured":"Teraki Y, Shiohara T. IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption. J Allergy Clin Immunol. 2003, 112:609-15. 10.1016\/s0091-6749(03)01624-5","journal-title":"J Allergy Clin Immunol"},{"key":"ref7","unstructured":"Medscape. Fixed Drug Eruptions. (2022). Accessed: March 24, 2022: http:\/\/Medscape."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(94)70007-9","article-title":"Genetic susceptibility to fixed drug eruption: Evidence for a link with HLA-B22","volume":"30","author":"Riccardo Pellicano","unstructured":"Riccardo Pellicano, Giovanni Ciavarella, Michele Lomuto, Giuseppe Di Giorgio. Genetic susceptibility to fixed drug eruption: Evidence for a link with HLA-B22. Journal of the American Academy of Dermatology,Volume. 30:52-54. 10.1016\/S0190-9622(94)70007-9","journal-title":"Journal of the American Academy of Dermatology,Volume"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/DSS.0000000000003216","article-title":"Hyperpigmentation from fixed drug eruption successfully treated with a low-fluence 1064 nm Nd:YAG picosecond laser","volume":"47","author":"Watchmaker J","year":"2021","unstructured":"Watchmaker J, Kandula P. Hyperpigmentation from fixed drug eruption successfully treated with a low-fluence 1064 nm Nd:YAG picosecond laser. Dermatol Surg. 2021, 47:1529-30. 10.1097\/DSS.0000000000003216","journal-title":"Dermatol Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.0101a09","article-title":"Histopathology of drug eruptions - general criteria, common patterns, and differential diagnosis","volume":"1","author":"Weyers W","year":"2011","unstructured":"Weyers W, Metze D. Histopathology of drug eruptions - general criteria, common patterns, and differential diagnosis. Dermatol Pract Concept. 2011, 1:33-47. 10.5826\/dpc.0101a09","journal-title":"Dermatol Pract Concept"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.184778","article-title":"Fixed drug eruption due to levocetirizine","volume":"7","author":"Jhaj R","year":"2016","unstructured":"Jhaj R, Asati DP, Chaudhary D. Fixed drug eruption due to levocetirizine. J Pharmacol Pharmacother. 2016, 7:109-11. 10.4103\/0976-500X.184778","journal-title":"J Pharmacol Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/107781-fixed-drug-eruption-an-underrecognized-cutaneous-manifestation-of-a-drug-reaction-in-the-primary-care-setting","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:30Z","timestamp":1707508110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/107781-fixed-drug-eruption-an-underrecognized-cutaneous-manifestation-of-a-drug-reaction-in-the-primary-care-setting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.28299","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,23]]}}}